FDA Approved: TIROSINT — Supplemental Application (IBSA Pharma Inc.)

View source ↗

Summary

The FDA approved a supplemental application for TIROSINT (levothyroxine sodium) by IBSA Pharma Inc., updating the product labeling as part of the supplemental s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hypothyroidism
• Goiter
• Hypothyroidism
• Thyroid Cancer

Drugs mentioned

• TIROSINT (Levothyroxine Sodium)

Snippet

SUPPL AP for TIROSINT (LEVOTHYROXINE SODIUM)